Trials / Completed
CompletedNCT03042390
Study of the Effectiveness and Safety of Darunavir/Cobicistat (DRV/c) Containing Regimens in Routine Clinical Practice
Multicenter Retrospective Study of the Effectiveness and Safety of Darunavir/Cobicistat (DRV/c) Containing Regimens in Routine Clinical Practice
- Status
- Completed
- Phase
- —
- Study type
- Observational
- Enrollment
- 762 (actual)
- Sponsor
- Fundacion SEIMC-GESIDA · Academic / Other
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
This is a retrospective observational study of patients who have taken a regimen containing DRV / c at least 24 weeks prior to study initiation
Detailed description
The study will include 750 patients and will record data at 24 weeks. The study will also record data at 48 weeks for those patients whom these data are available
Conditions
Timeline
- Start date
- 2016-12-23
- Primary completion
- 2017-05-09
- Completion
- 2017-05-09
- First posted
- 2017-02-03
- Last updated
- 2020-02-05
Locations
20 sites across 1 country: Spain
Source: ClinicalTrials.gov record NCT03042390. Inclusion in this directory is not an endorsement.